Researchers from University College London have gained a new understanding of how changes in the immune system can foreshadow the expression of Huntington’s disease by 16 years. The research on this fatal neurodegenerative disease was published online in the Journal of Experimental Medicine and shed some light on possible therapies that would target the immune system.

• Dr. Blair Leavitt, senior research neurologist and scientist at The Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute at BC Children’s Hospital, Director of the Canadian Genetic Disease Network Transgenic Core Facility, Asst. Professor, Dept. of Medical Genetics at UBC and Neurologist, UBC Neurogenetics and HD Medical Clinics